bluebird bio
BLUE
#9791
Rank
A$72.62 M
Marketcap
A$7.42
Share price
0.00%
Change (1 day)
-77.49%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: A$72.62 Million

As of January 2026 bluebird bio has a market cap of A$72.62 Million. This makes bluebird bio the world's 9791th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$72.66 M-44.29%
2024A$0.13 B-66.59%
2023A$0.39 B-53.69%
2022A$0.84 B-12.73%
2021A$0.96 B-74.14%
2020A$3.73 B-46.18%
2019A$6.93 B-9.97%
2018A$7.70 B-31.15%
2017A$11.19 B250.61%
2016A$3.19 B-1.82%
2015A$3.25 B-10.26%
2014A$3.62 B543.67%
2013A$0.56 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
A$16.07 B 22,037.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$16.31 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$173.14 B 238,302.34%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
A$0.21 B 199.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$413.78 B 569,629.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A$15.11 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA